Hanna Kirollos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jeffrey Matous, MD, leads a panel discussion surrounding the use of bispecifics treatment of relapsed / refractory multiple myeloma.

United statesKirollos hannaHanna kirollosJeffrey matousBeth faimanZahra mahmoudjafariUniversity of kansas cancer centerColorado blood cancer institute in denverPeer exchangeMayo clinic college of medicineBispecifics in relapsedRefractory multipleColorado blood cancer instituteCleveland clinicClinical pharmacy managerKansas cancer